Adkins-Jackson, P. B., & Belsky, D. W. (2022). Alzheimer’s disease risk biomarkers: progress and challenges. The Lancet Healthy Longevity, 3(9), e575–e576. https://doi.org/10.1016/s2666-7568(22)00191-x

Zhu, X., Liu, Y., Habeck, C. G., Stern, Y., Lee, S., & for-the-Alzheimer’s-Disease-Neuroimaging-Initiative. (2022). Transfer learning for cognitive reserve quantification. NeuroImage, 258, 119353. https://doi.org/10.1016/j.neuroimage.2022.119353

Sun, J., Ludvigsson, J. F., Ingre, C., Piehl, F., Wirdefeldt, K., Zagai, U., Ye, W., & Fang, F. (2022). Hospital-treated infections in early- and mid-life and risk of Alzheimer’s disease, Parkinson’s disease, and amyotrophic lateral sclerosis: A nationwide nested case-control study in Sweden. PLOS Medicine, 19(9), e1004092. https://doi.org/10.1371/journal.pmed.1004092

Crotty, G. F., Keavney, J. L., Alcalay, R. N., Marek, K., Marshall, G. A., Rosas, H. D., & Schwarzschild, M. A. (2022). Planning for Prevention of Parkinson Disease. Neurology, 99(7_Supplement_1), 1–9. https://doi.org/10.1212/wnl.0000000000200789

Tahami Monfared, A. A., Stern, Y., Doogan, S., Irizarry, M., & Zhang, Q. (2022). Stakeholder Insights in Alzheimer’s Disease: Natural Language Processing of Social Media Conversations. Journal of Alzheimer’s Disease, 89(2), 695–708. https://doi.org/10.3233/jad-220422

Du, F., Yu, Q., Kanaan, N. M., & Yan, S. S. (2022). Mitochondrial oxidative stress contributes to the pathological aggregation and accumulation of tau oligomers in Alzheimer’s disease. Human Molecular Genetics, 31(15), 2498–2507. https://doi.org/10.1093/hmg/ddab363

Janelidze, S., Christian, B. T., Price, J., Laymon, C., Schupf, N., Klunk, W. E., Lott, I., Silverman, W., Rosas, H. D., Zaman, S., Mapstone, M., Lai, F., Ances, B. M., Handen, B. L., & Hansson, O. (2022). Detection of Brain Tau Pathology in Down Syndrome Using Plasma Biomarkers. JAMA Neurology, 79(8), 797. https://doi.org/10.1001/jamaneurol.2022.1740

Rabin, J. S., Nichols, E., La Joie, R., Casaletto, K. B., Palta, P., Dams-O’Connor, K., Kumar, R. G., George, K. M., Satizabal, C. L., Schneider, J. A., Pa, J., & Brickman, A. M. (2022). Cerebral amyloid angiopathy interacts with neuritic amyloid plaques to promote tau and cognitive decline. Brain, 145(8), 2823–2833. https://doi.org/10.1093/brain/awac178

Kamath, V., Senjem, M. L., Spychalla, A. J., Chen, H., Palta, P., Mosley, T. H., Windham, B. G., Griswold, M., Knopman, D. S., Gottesman, R. F., Jack, C. R., Sharrett, A. R., & Schneider, A. L. C. (2022). The Neuroanatomic Correlates of Olfactory Identification Impairment in Healthy Older Adults and in Persons with Mild Cognitive Impairment. Journal of Alzheimer’s Disease, 89(1), 233–245. https://doi.org/10.3233/jad-220228

Rajabli, F., Beecham, G. W., Hendrie, H. C., Baiyewu, O., Ogunniyi, A., Gao, S., Kushch, N. A., Lipkin-Vasquez, M., Hamilton-Nelson, K. L., Young, J. I., Dykxhoorn, D. M., Nuytemans, K., Kunkle, B. W., Wang, L., Jin, F., Liu, X., Feliciano-Astacio, B. E., Schellenberg, G. D., … Vance, J. M. (2022). A locus at 19q13.31 significantly reduces the ApoE ε4 risk for Alzheimer’s Disease in African Ancestry. PLOS Genetics, 18(7), e1009977. https://doi.org/10.1371/journal.pgen.1009977

Peris, L., Parato, J., Qu, X., Soleilhac, J. M., Lanté, F., Kumar, A., Pero, M. E., Martínez-Hernández, J., Corrao, C., Falivelli, G., Payet, F., Gory-Fauré, S., Bosc, C., Blanca Ramirez, M., Sproul, A., Brocard, J., Di Cara, B., Delagrange, P., Buisson, A., … Andrieux, A. (2022). Tubulin tyrosination regulates synaptic function and is disrupted in Alzheimer’s disease. Brain, 145(7), 2486–2506. https://doi.org/10.1093/brain/awab436

Lee, A. J., Raghavan, N. S., Bhattarai, P., Siddiqui, T., Sariya, S., Reyes-Dumeyer, D., Flowers, X. E., Cardoso, S. A. L., De Jager, P. L., Bennett, D. A., Schneider, J. A., Menon, V., Wang, Y., Lantigua, R. A., Medrano, M., Rivera, D., Jiménez-Velázquez, I. Z., Kukull, W. A., Brickman, A. M., … Mayeux, R. (2022). FMNL2 regulates gliovascular interactions and is associated with vascular risk factors and cerebrovascular pathology in Alzheimer’s disease. Acta Neuropathologica, 144(1), 59–79. https://doi.org/10.1007/s00401-022-02431-6

Eissman, J. M., Dumitrescu, L., Mahoney, E. R., Smith, A. N., Mukherjee, S., Lee, M. L., Scollard, P., Choi, S. E., Bush, W. S., Engelman, C. D., Lu, Q., Fardo, D. W., Trittschuh, E. H., Mez, J., Kaczorowski, C. C., Hernandez Saucedo, H., Widaman, K. F., Buckley, R. F., Properzi, M. J., … Hohman, T. J. (2022). Sex differences in the genetic architecture of cognitive resilience to Alzheimer’s disease. Brain, 145(7), 2541–2554. https://doi.org/10.1093/brain/awac177

Goldman, J. E. (2022). Alzheimer Type I Astrocytes: Still Mysterious Cells. Journal of Neuropathology & Experimental Neurology, 81(8), 588–595. https://doi.org/10.1093/jnen/nlac043

Cosacak, M. I., Bhattarai, P., De Jager, P. L., Menon, V., Tosto, G., & Kizil, C. (2022). Single Cell/Nucleus Transcriptomics Comparison in Zebrafish and Humans Reveals Common and Distinct Molecular Responses to Alzheimer’s Disease. Cells, 11(11), 1807. https://doi.org/10.3390/cells11111807

Haage, V., & De Jager, P. L. (2022). Neuroimmune contributions to Alzheimer’s disease: a focus on human data. Molecular Psychiatry, 27(8), 3164–3181. https://doi.org/10.1038/s41380-022-01637-0

Kumar, J. S. D., Molotkov, A., Kim, J., Carberry, P., Idumonyi, S., Castrillon, J., Duff, K., Shneider, N. A., & Mintz, A. (2022). Preclinical evaluation of a microtubule PET ligand [11C]MPC-6827 in tau and amyotrophic lateral sclerosis animal models. Pharmacological Reports, 74(3), 539–544. https://doi.org/10.1007/s43440-022-00359-y

Kizil, C., Sariya, S., Kim, Y. A., Rajabli, F., Martin, E., Reyes-Dumeyer, D., Vardarajan, B., Maldonado, A., Haines, J. L., Mayeux, R., Jiménez-Velázquez, I. Z., Santa-Maria, I., & Tosto, G. (2022). Admixture Mapping of Alzheimer’s disease in Caribbean Hispanics identifies a new locus on 22q13.1. Molecular Psychiatry, 27(6), 2813–2820. https://doi.org/10.1038/s41380-022-01526-6

Gu, Y., Kociolek, A., Fernandez, K. K., Cosentino, S. A., Zhu, C. W., Jin, Z., Leverenz, J. B., & Stern, Y. B. (2022). Clinical Trajectories at the End of Life in Autopsy-Confirmed Dementia Patients With Alzheimer Disease and Lewy Bodies Pathologies. Neurology, 98(21). https://doi.org/10.1212/wnl.0000000000200259

Tsiakiri, A., Koutzmpi, V., Megagianni, S., Toumaian, M., Geronikola, N., Despoti, A., Kanellopoulou, S., Arampatzi, X., Margioti, E., Davila, A., Zoi, P., Kalligerou, F., Liozidou, A., Tsapanou, A., & Sakka, P. (2022). Remote neuropsychological evaluation of older adults. Applied Neuropsychology: Adult, 31(5), 796–803. https://doi.org/10.1080/23279095.2022.2074850

Kim, H., Levine, A., Cohen, D., Gehrman, P., Zhu, X., Devanand, D. P., Lee, S., & Goldberg, T. E. (2022). The Role of Amyloid, Tau, and APOE Genotype on the Relationship Between Informant-Reported Sleep Disturbance and Alzheimer’s Disease Risks. Journal of Alzheimer’s Disease, 87(4), 1567–1580. https://doi.org/10.3233/jad-215417

Reiken, S., Sittenfeld, L., Dridi, H., Liu, Y., Liu, X., & Marks, A. R. (2022). Alzheimer’s‐like signaling in brains of COVID‐19 patients. Alzheimer’s & Dementia, 18(5), 955–965. Portico. https://doi.org/10.1002/alz.12558

Chen, S., Acosta, D., Li, L., Liang, J., Chang, Y., Wang, C., Fitzgerald, J., Morrison, C., Goulbourne, C. N., Nakano, Y., Villegas, N. C. H., Venkataraman, L., Brown, C., Serrano, G. E., Bell, E., Wemlinger, T., Wu, M., Kokiko-Cochran, O. N., Popovich, P., … Fu, H. (2022). Wolframin is a novel regulator of tau pathology and neurodegeneration. Acta Neuropathologica, 143(5), 547–569. https://doi.org/10.1007/s00401-022-02417-4

Brickman, A. M., Manly, J. J., Honig, L. S., Sanchez, D., Reyes‐Dumeyer, D., Lantigua, R. A., Vonsattel, J. P., Teich, A. F., Kang, M. S., Dage, J. L., & Mayeux, R. (2022). Correlation of plasma and neuroimaging biomarkers in Alzheimer’s disease. Annals of Clinical and Translational Neurology, 9(5), 756–761. Portico. https://doi.org/10.1002/acn3.51529

Guisle, I., Canet, G., Pétry, S., Fereydouni-Forouzandeh, P., Morin, F., Kérauden, R., Whittington, R. A., Calon, F., Hébert, S. S., & Planel, E. (2022). Sauna-like conditions or menthol treatment reduce tau phosphorylation through mild hyperthermia. Neurobiology of Aging, 113, 118–130. https://doi.org/10.1016/j.neurobiolaging.2022.02.011

Libon, D. J., Swenson, R., Lamar, M., Price, C. C., Baliga, G., Pascual-Leone, A., Au, R., Cosentino, S., & Andersen, S. L. (2022). The Boston Process Approach and Digital Neuropsychological Assessment: Past Research and Future Directions. Journal of Alzheimer’s Disease, 87(4), 1419–1432. https://doi.org/10.3233/jad-220096

Rippon, B., Palta, P., Tahmi, M., Sherwood, G., Soto, L., Cespedes, S., Mesen, Y., He, H., Laing, K., Moreno, H., Teresi, J., Razlighi, Q., Brickman, A. M., Zetterberg, H., & Luchsinger, J. A. (2022). Plasma Amyloid and in vivo Brain Amyloid in Late Middle-Aged Hispanics. Journal of Alzheimer’s Disease, 87(3), 1229–1238. https://doi.org/10.3233/jad-210391

Devanand, D. P., Lee, S., Huey, E. D., & Goldberg, T. E. (2022). Associations Between Neuropsychiatric Symptoms and Neuropathological Diagnoses of Alzheimer Disease and Related Dementias. JAMA Psychiatry, 79(4), 359. https://doi.org/10.1001/jamapsychiatry.2021.4363

Barker, M. S., Gottesman, R. T., Manoochehri, M., Chapman, S., Appleby, B. S., Brushaber, D., Devick, K. L., Dickerson, B. C., Domoto-Reilly, K., Fields, J. A., Forsberg, L. K., Galasko, D. R., Ghoshal, N., Goldman, J., Graff-Radford, N. R., Grossman, M., Heuer, H. W., Hsiung, G.-Y., Knopman, D. S., … Weintraub, S. (2022). Proposed research criteria for prodromal behavioural variant frontotemporal dementia. Brain, 145(3), 1079–1097. https://doi.org/10.1093/brain/awab365

Neuner, S. M., Telpoukhovskaia, M., Menon, V., O’Connell, K. M. S., Hohman, T. J., & Kaczorowski, C. C. (2022). Translational approaches to understanding resilience to Alzheimer’s disease. Trends in Neurosciences, 45(5), 369–383. https://doi.org/10.1016/j.tins.2022.02.005

Gabrielli, M., Prada, I., Joshi, P., Falcicchia, C., D’Arrigo, G., Rutigliano, G., Battocchio, E., Zenatelli, R., Tozzi, F., Radeghieri, A., Arancio, O., Origlia, N., & Verderio, C. (2022). Microglial large extracellular vesicles propagate early synaptic dysfunction in Alzheimer’s disease. Brain, 145(8), 2849–2868. https://doi.org/10.1093/brain/awac083

Yu, L., Boyle, P. A., Wingo, A. P., Yang, J., Wang, T., Buchman, A. S., Wingo, T. S., Seyfried, N. T., Levey, A. I., De Jager, P. L., Schneider, J. A., & Bennett, D. A. (2022). Neuropathologic Correlates of Human Cortical Proteins in Alzheimer Disease and Related Dementias. Neurology, 98(10). https://doi.org/10.1212/wnl.0000000000013252

Zammit, A. R., Yu, L., Petyuk, V., Schneider, J. A., De Jager, P. L., Klein, H.-U., Bennett, D. A., & Buchman, A. S. (2022). Cortical Proteins and Individual Differences in Cognitive Resilience in Older Adults. Neurology, 98(13). https://doi.org/10.1212/wnl.0000000000200017

Jansen, W. J., Janssen, O., Tijms, B. M., Vos, S. J. B., Ossenkoppele, R., Visser, P. J., Aarsland, D., Alcolea, D., Altomare, D., von Arnim, C., Baiardi, S., Baldeiras, I., Barthel, H., Bateman, R. J., Van Berckel, B., Binette, A. P., Blennow, K., Boada, M., … Zetterberg, H. (2022). Prevalence Estimates of Amyloid Abnormality Across the Alzheimer Disease Clinical Spectrum. JAMA Neurology, 79(3), 228. https://doi.org/10.1001/jamaneurol.2021.5216

Doraiswamy, P. M., Goldberg, T. E., Qian, M., Linares, A. R., Nwosu, A., Nino, I., D’Antonio, J., Phillips, J., Ndouli, C., Hellegers, C., Michael, A. M., Petrella, J. R., Andrews, H., Sneed, J., & Devanand, D. P. (2022). Validity of the Web-Based, Self-Directed, NeuroCognitive Performance Test in Mild Cognitive Impairment. Journal of Alzheimer’s Disease, 86(3), 1131–1136. https://doi.org/10.3233/jad-220015

Carlson, S., Kim, H., Devanand, D. P., & Goldberg, T. E. (2022). Novel approaches to measuring neurocognitive functions in Alzheimer’s disease clinical trials. Current Opinion in Neurology, 35(2), 240–248. https://doi.org/10.1097/wco.0000000000001041

Johnson, E. C. B., Carter, E. K., Dammer, E. B., Duong, D. M., Gerasimov, E. S., Liu, Y., Liu, J., Betarbet, R., Ping, L., Yin, L., Serrano, G. E., Beach, T. G., Peng, J., De Jager, P. L., Haroutunian, V., Zhang, B., Gaiteri, C., Bennett, D. A., Gearing, M., … Seyfried, N. T. (2022). Large-scale deep multi-layer analysis of Alzheimer’s disease brain reveals strong proteomic disease-related changes not observed at the RNA level. Nature Neuroscience, 25(2), 213–225. https://doi.org/10.1038/s41593-021-00999-y

Chhatwal, J. P., Schultz, S. A., McDade, E., Schultz, A. P., Liu, L., Hanseeuw, B. J., Joseph-Mathurin, N., Feldman, R., Fitzpatrick, C. D., Sparks, K. P., Levin, J., Berman, S. B., Renton, A. E., Esposito, B. T., Fernandez, M. V., Sung, Y. J., Lee, J. H., Klunk, W. E., Hofmann, A., … Sperling, R. A. (2022). Variant-dependent heterogeneity in amyloid β burden in autosomal dominant Alzheimer’s disease: cross-sectional and longitudinal analyses of an observational study. The Lancet Neurology, 21(2), 140–152. https://doi.org/10.1016/s1474-4422(21)00375-6

Yoon, S., Broadwell, P., Alcantara, C., Davis, N., Lee, H., Bristol, A., Tipiani, D., Nho, J. Y., & Mittelman, M. (2022). Analyzing Topics and Sentiments from Twitter to Gain Insights to Refine Interventions for Family Caregivers of Persons with Alzheimer’s Disease and Related Dementias (ADRD) During COVID-19 Pandemic. Informatics and Technology in Clinical Care and Public Health. https://doi.org/10.3233/shti210886

Menardi, A., Rossi, S., Koch, G., Hampel, H., Vergallo, A., Nitsche, M. A., Stern, Y., Borroni, B., Cappa, S. F., Cotelli, M., Ruffini, G., El-Fakhri, G., Rossini, P. M., Dickerson, B., Antal, A., Babiloni, C., Lefaucheur, J.-P., Dubois, B., Deco, G., … Santarnecchi, E. (2022). Toward noninvasive brain stimulation 2.0 in Alzheimer’s disease. Ageing Research Reviews, 75, 101555. https://doi.org/10.1016/j.arr.2021.101555

Gu, Y., Nishikawa, M., Brickman, A. M., Manly, J. J., Schupf, N., & Mayeux, R. P. (2021). Association of Dietary Prebiotic Consumption with Reduced Risk of Alzheimer’s Disease in a Multiethnic Population. Current Alzheimer Research, 18(12), 984–992. https://doi.org/10.2174/1567205019666211222115142

Zhuravleva, V., Vaz-Silva, J., Zhu, M., Gomes, P., Silva, J. M., Sousa, N., Sotiropoulos, I., & Waites, C. L. (2021). Rab35 and glucocorticoids regulate APP and BACE1 trafficking to modulate Aβ production. Cell Death & Disease, 12(12). https://doi.org/10.1038/s41419-021-04433-w

Lee, M., Woo, J., Kim, D.-H., Yang, Y.-M., Lee, E. Y., Kim, J.-H., Kang, S.-G., Shim, J.-K., & Park, J.-Y. (2021). A novel paper MAP method for rapid high resolution histological analysis. Scientific Reports, 11(1). https://doi.org/10.1038/s41598-021-02632-1

Ma, Y., Dammer, E. B., Felsky, D., Duong, D. M., Klein, H.-U., White, C. C., Zhou, M., Logsdon, B. A., McCabe, C., Xu, J., Wang, M., Wingo, T. S., Lah, J. J., Zhang, B., Schneider, J., Allen, M., Wang, X., Ertekin-Taner, N., Seyfried, N. T., … De Jager, P. L. (2021). Atlas of RNA editing events affecting protein expression in aged and Alzheimer’s disease human brain tissue. Nature Communications, 12(1). https://doi.org/10.1038/s41467-021-27204-9